Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.83 | 1.73 |
NAV | ₹23.53 | ₹74.79 |
Fund Started | 14 Feb 2020 | 21 Oct 2008 |
Fund Size | ₹3795.12 Cr | ₹5659.43 Cr |
Exit Load | For units more than 12% of the investments, an exit load of 1% if redeemed within 365 days. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.44% | 8.62% |
3 Year | 17.12% | 22.28% |
5 Year | 18.17% | 17.32% |
1 Year
3 Year
5 Year
Equity | 57.91% | 61.50% |
Cash | 31.01% | 21.96% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 4.46% |
Reliance Industries Ltd. | 4.32% |
HDFC Bank Ltd. | 4.28% |
Bharti Airtel Ltd. | 2.46% |
State Bank of India | 2.45% |
Axis Bank Ltd. | 2.27% |
Larsen & Toubro Ltd. | 1.38% |
Adani Ports and Special Economic Zone Ltd. | 1.34% |
Infosys Ltd. | 1.31% |
Hero Motocorp Ltd. | 1.29% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 4.02% |
Bharti Airtel Ltd. | 2.83% |
HDFC Bank Ltd. | 2.66% |
Infosys Ltd. | 2.62% |
ITC Ltd. | 2.36% |
Tata Consultancy Services Ltd. | 2.36% |
HCL Technologies Ltd. | 2.35% |
Bajaj Finserv Ltd. | 2.09% |
Reliance Industries Ltd. | 2.03% |
Sun Pharmaceutical Industries Ltd. | 1.68% |
Name | Murthy Nagarajan | Sunil Madhukar Patil |
Start Date | 03 May 2021 | 12 Dec 2022 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation. | The Scheme seeks to achieve long term capital appreciation by investing predominantly in a diversified portfolio of equity and equity related instruments. The fund also invests in debt and money market instruments with a view to generate regular income. The fund also invests in Gold ETFs. The portfolio allocation is managed dynamically. |
Launch Date | 14 Feb 2020 | 21 Oct 2008 |
Description
Launch Date